Conditions and Guidelines


The Foundation offers a research fellowship in clinical diabetes with the following options: 


Three year full-time
Four year full-time with year 1 taught MSc

Five year part time

Who can apply?  


  • Specialist registrars who have membership of a Royal College and are currently training and wishing to pursue a career in either paediatric or adult diabetes and endocrinology.
  • General Practitioners (GPs) or GP trainees with an interest in diabetes.
  • Nurses with experience in diabetes who wish to study for a higher degree.
  • Healthcare professionals (e.g. someone who requires registraton to practice within the NHS).


Applicants for fellowship awards must be qualified, living, working and registered in the UK. Qualified means a medical qualification (such as MBBA, MBBS), nursing or midwifery qualification, or other recognised healthcare qualification (e.g. the Health and Care Professions Council).

For the successful applicant the Foundation will pay the salary appropriate for their experience, grade and position, plus consumables.  Training and support is available and additional funding for attendance to professional conferences where the research is presented.


This fellowship is intended to result in a higher degree such as an MD or a PhD. People who already hold an MD or PhD are not eligible.

It is preferred that recipients be supernumerary and not to participate in regular on call duties although this can be considered.

The amount awarded per Fellowship includes the salary, superannuation, national insurance and London weighting allowance (if applicable).

An itemised allowance for consumables of up to a maximum of £8,000 per annum may also be provided.   If consumables exceed £8k, this must be documented in the application and how this difference will be funded.

PhD fees should be itemised on your application.

No institutional overheads will be paid as the Foundation is a Registered Charity.

Travel to meetings to present results from the research and publication costs should not be included but can be applied for separately.

Fellows must attend one meeting per year to present their work to the Board of Trustees.

Objectives will be set by your supervisor and annual reports on progress should be submitted to the Foundation to secure the following years funding.

A copy of the final MD or PhD thesis and all published works are to be provided, to the Foundation.

Excess treatment costs within the NHS must be applied for by the applicant.

The application procedure involves two steps:

Preliminary Application

Application forms are available on the Foundation web site or by contacting     

All applications must be submitted electronically to    and a hard copy of the signature page to: The Novo Nordisk UK Research Foundation, Foundation Administrator, 3 City Place, Beehive Ring Road, Gatwick, RH6 0PA.

Applications will be reviewed by the Research Selection Committee and External Reviewers (including CVs).

A short list of candidates will be invited to submit a Full Application. 

Full Application

Full Application forms will be sent to the short listed candidates.

Full applications must have a named fellow on the application.


Applications should be submitted electronically to: and a hard copy of the signature page to: The Novo Nordisk UK Research Foundation, Foundation Administrator, 3 City Place, Beehive Ring Road, Gatwick, RH6 0PA.


Applicants are required to present their application at the Research Selection Committee Meeting, a 10 minute presentation and 10 minutes to take questions. 


Research Fellowships are awarded by the Trustees of The Novo Nordisk UK Research Foundation following evaluation by the Foundation Research Selection Committee (RSC) comprising specialists in diabetes and in accordance with the Association of Medical Research Charities Best Practice for Peer Review.  Applications are evaluated with respect to the scientific merit as well as the elements of supervision and training provided for the Fellow. 

The Research Fellowships are awarded for the purpose stated in the notification from the Board.  The Fellowship agreed, unless stated otherwise, is based on the application.  The initial Fellowship is for one year, which can be extended annually depending on the term of the fellowship based on satisfactory annual progress reports submitted to the Chairman of the RSC. Dates for submission of reports will be agreed with each Fellow and Supervisor.  Funds cannot be used in any way other than as salary, higher degree fees for the Fellow and as consumable allowance in support of the research project.  If the full amount of the Fellowship is not used in the course of the project, the balance must be returned to the Foundation.  It is important to note that funding of the salary of the fellow does not constitute a contract of employment with the fellow and that the Fellowship is an award given by the Foundation to the supervisor/host institution. (Preliminary applications may be made for an award without having identified a suitable candidate but a suitable candidate must be named in the full application). 

On completion of the Research Fellowship a final report must be submitted to the Board and a bound copy of the final MD or PhD thesis provided. 

In all publications a statement acknowledging support of The Novo Nordisk UK Research Foundation should be included.  



Trustees expect all award recipients to adhere to appropriate regulations, and where appropriate the Research Governance Framework for Health and Social Care Research (1).


Applicants should also refer to the Policies and Guidelines of the Foundation, which should be read in conjunction with this document, available on the website.


For all dates, regulations and application forms contact Jackie Shuttlewood  01293 762009


(1) The Research Governance Framework for Health and Social Care. 2nd Edition Department of Health 2005.

Unsuccessful applications will be deleted from our records 12 months after a decision on funding is received.
The sole sponsor of The Novo Nordisk UK Research Foundation is Novo Nordisk Ltd


September 2019